Tinengotinib
4-[9-(2-chlorophenyl)-6-methyl-2,4,5,8,12-pentazatricyclo[8.4.0.03,7]tetradeca-1(14),3,6,8,10,12-hexaen-13-yl]morpholine
Molecular Identity
Tinengotinib
4-[9-(2-chlorophenyl)-6-methyl-2,4,5,8,12-pentazatricyclo[8.4.0.03,7]tetradeca-1(14),3,6,8,10,12-hexaen-13-yl]morpholine
PubChem CID: 137279257
2D Structure
Properties
C20H19ClN6O
Molecular Formula
394.90
Molecular Weight
g/mol
394.1309
Exact Mass
Da
3.4
XLogP
Drug-like (Lipinski: < 5)
78.4
TPSA
Good oral absorption (< 140 A²)
2
H-Bond Donors
6
H-Bond Acceptors
585
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
TinengotinibTT-00420WZ9TJ0L9Y8TINENGOTINIB [INN]UNII-WZ9TJ0L9Y8Example 6 [US10889586B2]TT00420Example 6 (US10889586B2)5-(2-chlorophenyl)-3-methyl-8-(morpholin-4-yl)-1,10-dihydropyrazolo[4,3-b]pyrido[4,3-e][1,4]diazepine4-(5-(2-Chlorophenyl)-3-Methyl-2,10-Dihydropyrazolo(4,3-B) Pyrido(4,3-E)(1,4)Diazepin-8-Yl) Morpholine4-(5-(2-Chlorophenyl)-3-Methyl-2,10-Dihydropyrazolo[4,3-B] Pyrido[4,3-E][1,4]Diazepin-8-Yl) Morpholine5-(2-chlorophenyl)-3-methyl-8-(morpholin-4-yl)-1,10-dihydropyrazolo(4,3-b)pyrido(4,3-e)(1,4)diazepineRefChem:190065Multi-kinase Inhibitor TT-00420Multiple Kinase Inhibitor TT-00420
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Tinengotinib
Loading drug network...